Skip to main content

Table 3 Secondary analysis: cost and outcome comparison of the proposed algorithm versus the current algorithm in the public healthcare system in Hong Kong, with 41.8% of women willing to pay for the out-of-pocket aCGH

From: Cost-effectiveness analysis of chromosomal microarray as a primary test for prenatal diagnosis in Hong Kong